fh535 and Cystadenoma--Mucinous

fh535 has been researched along with Cystadenoma--Mucinous* in 1 studies

Other Studies

1 other study(ies) available for fh535 and Cystadenoma--Mucinous

Article	Year
Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice. International journal of molecular sciences, 2021, Apr-28, Volume: 22, Issue:9 Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; beta Catenin; Cell Line, Tumor; Cystadenoma, Mucinous; Female; Humans; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Neoplasms, Experimental; Pancreas; Pancreatic Neoplasms; Peutz-Jeghers Syndrome; Protein Serine-Threonine Kinases; Sulfonamides; Wnt Signaling Pathway	2021

Article

Year

Inhibition of β-Catenin Activity Abolishes LKB1 Loss-Driven Pancreatic Cystadenoma in Mice.

International journal of molecular sciences, 2021, Apr-28, Volume: 22, Issue:9

Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; beta Catenin; Cell Line, Tumor; Cystadenoma, Mucinous; Female; Humans; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Mutation; Neoplasms, Experimental; Pancreas; Pancreatic Neoplasms; Peutz-Jeghers Syndrome; Protein Serine-Threonine Kinases; Sulfonamides; Wnt Signaling Pathway

2021